The Impact of Bariatric Surgery on the Muscle Mass in Patients with Obesity: 2-Year Follow-up.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
03 2022
Historique:
received: 09 09 2021
accepted: 14 11 2021
revised: 11 11 2021
pubmed: 1 12 2021
medline: 16 4 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

Bariatric surgery (BS) induces a significant and sustained weight loss in patients with severe obesity (SO). Nevertheless, apart from significantly reducing body fat, fat-free mass (FFM) might also be lost. At present, there is little and controversial data in the literature regarding the impact of BS on FFM. In recent years, bioimpedance (BIA) has emerged as a reliable test to assess body composition easily to use in the daily clinical practice. On the bases, the aim of the present study is to evaluate the impact of BS on the FFM, evaluated by means of BIA. This is a prospective, observational study, including consecutive patients with SO that underwent BS between February 2018 and February 2019 at our center. At baseline, 1, 6, 12, and 24 months after the BS, all the patients underwent complete medical history, physical and anthropometric evaluation, and body composition assessment by means of BIA (using Bodystat QuadScan4000®). Eighty-five patients with SO were recruited, 72.9% females, aged 45.54 ± 9.98 years, pre-BS BMI 43.87 ± 6.52 kg/m Significant and early loss of FFM in patients with SO that undergo BS was seen, not related to protein metabolism parameters or the BS technique used, suggesting an independent mechanism.

Identifiants

pubmed: 34846686
doi: 10.1007/s11695-021-05815-x
pii: 10.1007/s11695-021-05815-x
pmc: PMC8866285
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

625-633

Informations de copyright

© 2021. The Author(s).

Références

Stensel D. Obesity and diabetes. Exerc Physiol Spec Popul. 2008;13(2):21–49.
doi: 10.1016/B978-0-443-10343-8.00002-0
Mc Farlane SI. Obesity, obstructive sleep apnea and type 2 diabetes mellitus: epidemiology and pathophysiologic insights. Sleep Med Disord Int J. 2018;2(3):52–8.
doi: 10.15406/smdij.2018.02.00045
Kahn BB, Flier JS. On diabetes: insulin resistance Obesity and insulin resistance. J Clin Invest. 2000;106(4):473–81.
doi: 10.1172/JCI10842
Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 2017;60(5):865–72.
doi: 10.1007/s00125-016-4196-9
Janssen I, Ross R. Linking age-related changes in skeletal muscle mass and composition with metabolism and disease. J Nutr Heal Aging. 2005;9(6):408–19.
Johnson Stoklossa CA, Sharma AM, Forhan M, Siervo M, Padwal RS, Prado CM. Prevalence of sarcopenic obesity in adults with class II/III obesity using different diagnostic criteria. J Nutr Metab. 2017;2017.
Khadra D, Itani L, Tannir H, Kreidieh D, El MD, El GM. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis. World J Diabetes. 2019;10(5):311–23.
doi: 10.4239/wjd.v10.i5.311
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
doi: 10.1093/ageing/afy169
Sivakumar J, Chong L, Ward S, Sutherland TR, Read M, Hii MW. Body composition changes following a very-low-calorie pre-operative diet in patients undergoing bariatric surgery. Obes Surg. 2020;30(1):119–26.
doi: 10.1007/s11695-019-04174-y
Cruz Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Maurits Vandewoude MZ. Sarcopenia: consenso europeo sobre su definición y diagnóstico. Age Ageing. 2010;39(4):412–23.
doi: 10.1093/ageing/afq034
Pateyjohns IR, Brinkworth GD, Buckley JD, Noakes M, Clifton PM. Comparison of three bioelectrical impedance methods with DXA in overweight and obese men. Obesity. 2006;14(11):2064–70.
doi: 10.1038/oby.2006.241
Ruiz De Eguilaz MH, Martínez De Morentín B, Pérez-Diez S, Navas-Carretero S, Martínez JA. Estudio comparativo de medidas de composición corporal por absorciometría dual de rayos X, bioimpedancia y pliegues cutańeos en mujeres. An la Real Acad Nac Farm. 2010;76(2):209–22.
Lee K, Shin Y, Huh J, Sung YS, Lee IS, Yoon KH, et al. Recent issues on body composition imaging for sarcopenia evaluation. Korean J Radiol. 2019;20(2):205–17.
doi: 10.3348/kjr.2018.0479
Sjöström L et al. for the SOSS. Effects of bariatric surgery on mortality in Swedish obese subjects. 2007.
Mastino D, Robert M, Betry C, Laville M, Gouillat C, Disse E. Bariatric surgery outcomes in sarcopenic obesity. Obes Surg. 2016;26(10):2355–62.
doi: 10.1007/s11695-016-2102-7
Vaurs C, Diméglio C, Charras L, Anduze Y, Chalret du Rieu M, Ritz P. Determinants of changes in muscle mass after bariatric surgery. Diabetes Metab [Internet] 2015;41(5):416–421. Available from: https://doi.org/10.1016/j.diabet.2015.04.003
García Almeida JM, García García C, Bellido Castañeda V, Bellido GD. Nuevo enfoque de la nutrición. Valoración del estado nutricional del paciente: función y composición corporal. Nutr Hosp. 2018;35(3):1–14.
doi: 10.20960/nh.2027
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr. 2004;23(5):1226–43.
doi: 10.1016/j.clnu.2004.06.004
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis - part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430–53.
doi: 10.1016/j.clnu.2004.09.012
da Silva BR, Gonzalez MC, Cereda E, Prado CM. Exploring the potential role of phase angle as a marker of oxidative stress: a narrative review. Nutrition [Internet]. 2022;93:111493. Available from: https://doi.org/10.1016/j.nut.2021.111493
Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. 2021;1–7.
Anja BW, Danielzik S, Dörhöfer RP, Later W, Wiese S, Müller MJ. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. J Parenter Enter Nutr. 2006;30(4):309–16.
doi: 10.1177/0148607106030004309
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes. 2008;32:S56–9.
doi: 10.1038/ijo.2008.87
Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes [Internet] 2010;34(5):791–799. Available from: https://doi.org/10.1038/ijo.2010.5
Segal-Lieberman G, Segal P, Dicker D. Revisiting the role of bmi in the guidelines for bariatric surgery. Diabetes Care. 2016;39(August):S268–73.
doi: 10.2337/dcS15-3018
Fidilio E, Comas M, Giribés M, Cárdenas G, Vilallonga R, Palma F, et al. Evaluation of resting energy expenditure in subjects with severe obesity and its evolution after bariatric surgery. Obes Surg. 2021
Thibault R, Makhlouf AM, Mulliez A, Cristina Gonzalez M, Kekstas G, Kozjek NR, et al. Fat-free mass at admission predicts 28-day mortality in intensive care unit patients: the international prospective observational study Phase Angle Project. Intensive Care Med. 2016;42(9):1445–53.
doi: 10.1007/s00134-016-4468-3
Alves FD, Souza GC, Clausell N, Biolo A. Prognostic role of phase angle in hospitalized patients with acute decompensated heart failure. Clin Nutr. 2016;35(6):1530–4.
doi: 10.1016/j.clnu.2016.04.007
Norman K, Stobäus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R, et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr. 2010;92(3):612–9.
doi: 10.3945/ajcn.2010.29215
Barbosa-Silva MCG, Barros AJD, Wang J, Heymsfield SB, Pierson RN. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr. 2005;82(1):49–52.
doi: 10.1093/ajcn/82.1.49
Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96(9):2898–903.
doi: 10.1210/jc.2011-0435
Ostler JE, Maurya SK, Dials J, Roof SR, Devor ST, Ziolo MT, et al. Effects of insulin resistance on skeletal muscle growth and exercise capacity in type 2 diabetic mouse models. Am J Physiol - Endocrinol Metab. 2014;306(6):592–605.
doi: 10.1152/ajpendo.00277.2013
Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006;147(9):4160–8.
doi: 10.1210/en.2006-0251
Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, De Francisco A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13(Cvd).

Auteurs

Marta Comas Martínez (MC)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Research Group M3O, Methodology, Methods, Models and Outcomes of Health and Social Sciences, Faculty of Health Sciences and Welfare, University of Vic - Central University of Catalonia, Barcelona, Spain.

Enzamaria Fidilio Meli (EF)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Fiorella Palmas Candia (FP)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Francesca Filippi (F)

Clinical Pharmacology Department, University Hospital Vall d'Hebron, Barcelona, Spain.

Ramon Vilallonga (R)

Endocrine, Metabolic and Bariatric Unit, General Surgery Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Efrain Cordero (E)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Irene Hernández (I)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Alba Zabalegui Eguinoa (AZ)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Rosa Burgos (R)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Anna Vila (A)

Research Group M3O, Methodology, Methods, Models and Outcomes of Health and Social Sciences, Faculty of Health Sciences and Welfare, University of Vic - Central University of Catalonia, Barcelona, Spain.

Rafael Simó (R)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain. rafael.simo@vhir.org.
Endocrine, Metabolic and Bariatric Unit, General Surgery Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. rafael.simo@vhir.org.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. rafael.simo@vhir.org.

Andreea Ciudin (A)

Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain. aciudin@vhebron.net.
Endocrine, Metabolic and Bariatric Unit, General Surgery Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. aciudin@vhebron.net.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. aciudin@vhebron.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH